{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:03:27Z","timestamp":1788581007359,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2334-10-267","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T19:14:53Z","timestamp":1284491693000},"source":"Crossref","is-referenced-by-count":12,"title":["Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain"],"prefix":"10.1186","volume":"10","author":[{"given":"Asuncion","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Bleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"Aldamiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Camafort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Camino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepcion","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuncion","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Geijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Iribarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Labarga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseba","family":"Portu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Telenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Trapiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Trastoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompeyo","family":"Viciana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"1247_CR1","first-page":"295","volume":"6","author":"M Diez","year":"2002","unstructured":"Diez M, Huerta C, Moreno T, Caloto T, Guerra D, Pozo F, Alcaide J, Castells C, Cardenal JI, Dom\u00ednguez A, Gayoso P, Guti\u00e9rrez G, L\u00f3pez MJ, Mu\u00f1oz F, Navarro C, Pic\u00f3 M, Quir\u00f3s JR, Robles F, S\u00e1nchez JM, Vanaclocha H, Vega T, Multicentre Project for Tuberculosis Research (MPTR) Study Group: Tuberculosis in Spain: epidemiological pattern and clinical practice. Int J Tuberc Lung Dis. 2002, 6: 295-300.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1247_CR2","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/QAD.0b013e3282f1c933","volume":"21","author":"R Muga","year":"2007","unstructured":"Muga R, Ferreros I, Langohr K, de Olalla PG, Del Romero J, Quintana M, Alastrue I, Belda J, Tor J, P\u00e9rez-Hoyos S, Del Amo J, Spanish Multicenter Study Group of Seroconverters (GEMES): Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART. AIDS. 2007, 21: 2521-2527. 10.1097\/QAD.0b013e3282f1c933.","journal-title":"AIDS"},{"key":"1247_CR3","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","volume":"21","author":"JE Golub","year":"2007","unstructured":"Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B: The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2007, 21: 1441-1448. 10.1097\/QAD.0b013e328216f441.","journal-title":"AIDS"},{"key":"1247_CR4","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1086\/498315","volume":"41","author":"E Girardi","year":"2005","unstructured":"Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, Gill MJ, Dabis F, Reiss P, Kirk O, Bernasconi E, Grabar S, Justice A, Staszewski S, F\u00e4tkenheuer G, Sterne JA, Antiretroviral Therapy Cohort Collaboration: Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis. 2005, 41: 1772-1782. 10.1086\/498315.","journal-title":"Clin Infect Dis"},{"key":"1247_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1086\/510080","volume":"44","author":"L Elzi","year":"2007","unstructured":"Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H, Swiss HIV Cohort Study: Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis. 2007, 44: 94-102. 10.1086\/510080.","journal-title":"Clin Infect Dis"},{"key":"1247_CR6","first-page":"CD000171","volume":"1","author":"S Woldehanna","year":"2004","unstructured":"Woldehanna S, Volmink J: Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2004, 1: CD000171-","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"1247_CR7","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1086\/518662","volume":"196","author":"GJ Churchyard","year":"2007","unstructured":"Churchyard GJ, Scano F, Grant AD, Chaisson RE: Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis. 2007, 196 (Suppl 1): S52-62. 10.1086\/518662.","journal-title":"J Infect Dis"},{"key":"1247_CR8","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1371\/journal.pmed.0040238","volume":"24","author":"SA Munro","year":"2007","unstructured":"Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J: Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007, 24: e238-10.1371\/journal.pmed.0040238.","journal-title":"PLoS Med"},{"key":"1247_CR9","first-page":"1235","volume":"12","author":"Y Hirsch-Moverman","year":"2008","unstructured":"Hirsch-Moverman Y, Daftary A, Franks J, Colson PW: Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis. 2008, 12: 1235-1254.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1247_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1183\/09031936.01.00087901","volume":"18","author":"G Antonucci","year":"2001","unstructured":"Antonucci G, Girardi E, Raviglione M, Vanacore P, Angarano G, Chirianni A, Pagano G, Suter F, Lauria FN, Ippolito G: Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study. GISTA (Gruppo Italiano di Studio Tubercolosi e AIDS). Eur Respir J. 2001, 18: 369-375. 10.1183\/09031936.01.00087901.","journal-title":"Eur Respir J"},{"key":"1247_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.eimc.2009.06.008","volume":"28","author":"A Diaz","year":"2010","unstructured":"Diaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamar\u00eda JM, Telenti M, Trapiella L, Trastoy M, Viciana P: Factores asociados a la no realizaci\u00f3n de la prueba de la tuberculina en una cohorte de pacientes VIH positivos [Factors related to non-prescription of tuberculin skin testing in a cohort of HIV-infected people]. Enferm Infecc Microbiol Clin. 2010, 28: 215-21. 10.1016\/j.eimc.2009.06.008.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"1247_CR12","first-page":"1196","volume":"11","author":"M Diez","year":"2007","unstructured":"Diez M, Diaz A, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaria JM, Telenti M, Trapiella L, Trastoy M, Viciana P: Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain. Int J Tuberc Lung Dis. 2007, 11: 1196-1202.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1247_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1157\/13058025","volume":"22","author":"J Berenguer","year":"2004","unstructured":"Berenguer J, Laguna F, L\u00f3pez-Aldeguer J, Moreno S, Arribas JR, Arrizabalaga J, Baraia J, Casado JL, Cos\u00edn J, Polo R, Gonz\u00e1lez-Garc\u00eda J, Iribarren JA, Kindel\u00e1n JM, L\u00f3pez-Bernaldo de Quir\u00f3s JC, L\u00f3pez-V\u00e9lez R, Lorenzo JF, Lozano F, Mallolas J, Mir\u00f3 JM, Pulido F, Ribera E: Prevenci\u00f3n de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH. Recomendaciones de GESIDA\/Plan Nacional sobre el Sida [Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA\/National AIDS Plan recommendations]. Enferm Infecc Microbiol Clin. 2004, 22: 160-176. 10.1157\/13058025.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"1247_CR14","first-page":"24","volume":"98","author":"Ministerio de Sanidad y Consumo. Fondo de Investigaci\u00f3n Sanitaria","year":"1992","unstructured":"Ministerio de Sanidad y Consumo. Fondo de Investigaci\u00f3n Sanitaria: Consenso nacional para el control de la tuberculosis [National consensus on the control of tuberculosis in Spain]. Med Clin (Barc). 1992, 98: 24-31.","journal-title":"Med Clin (Barc)"},{"key":"1247_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S: Applied Logistic Regression. 2000, New York: Wiley-Interscience, 2","edition":"2"},{"key":"1247_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized Linear Models","author":"P McCullagh","year":"1989","unstructured":"McCullagh P, Nelder J: Generalized Linear Models. 1989, London: Chapman and Hall, 2","edition":"2"},{"key":"1247_CR17","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1378\/chest.122.4.1292","volume":"122","author":"M Narita","year":"2002","unstructured":"Narita M, Kellman M, Franchini DL, McMillan ME, Hollender ES, Ashkin D: Short-course rifamycin and pyrazinamide treatment for latent tuberculosis infection in patients with HIV infection. The 2-year experience of a comprehensive community-based program in Broward County, Florida. Chest. 2002, 122: 1292-1298. 10.1378\/chest.122.4.1292.","journal-title":"Chest"},{"key":"1247_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0025-7753(00)71496-5","volume":"115","author":"EM Mart\u00ednez Alfaro","year":"2000","unstructured":"Mart\u00ednez Alfaro EM, Cuadra F, Solera J, Maci\u00e1 MA, Geijo P, S\u00e1nchez Mart\u00ednez PA, Rodr\u00edguez Zapata M, Largo J, Sep\u00falveda MA, Rosa C, S\u00e1nchez L, Espinosa A, Mateos F, Blanch JJ: Evaluaci\u00f3n de dos pautas de quimioprofilaxis tuberculosa en pacientes infectados por el virus de la inmunodeficiencia humana [Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus]. Med Clin (Barc). 2000, 115: 161-165.","journal-title":"Med Clin (Barc)"},{"key":"1247_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1157\/13102265","volume":"25","author":"A Rivero","year":"2007","unstructured":"Rivero A, L\u00f3pez-Cort\u00e9s L, Castillo R, Verdejo J, Garc\u00eda MA, Mart\u00ednez-Marcos FJ, D\u00edez F, Escribano JC, Canueto J, Lozano F, Pasquau J, Hern\u00e1ndez JJ, M\u00e1rquez M, Kindel\u00e1n JM, Grupo Andaluz para el estudio de las Enfermedades Infecciosas (GAEI): Ensayo cl\u00ednico aleatorizado para evaluar tres pautas cortas de tratamiento de la infecci\u00f3n latente tuberculosa en pacientes infectados por el VIH [Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients]. Enferm Infecc Microbiol Clin. 2007, 25: 305-310. 10.1157\/13102265.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"1247_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1157\/13116320","volume":"130","author":"JM Pina-Guti\u00e9rrez","year":"2008","unstructured":"Pina-Guti\u00e9rrez JM, Ferrer-Traid A, Arias C, Sala-Farr\u00e9 MR, L\u00f3pez-Sanmart\u00edn JL: Cumplimiento y efectividad del tratamiento de la infecci\u00f3n tuberculosa con isoniazida durante 9 meses en una cohorte de 755 pacientes [Adherence and effectiveness of the treatment of latent tuberculosis infection with isoniazid for 9 months in a cohort of 755 patients]. Med Clin (Barc). 2008, 130: 165-171. 10.1157\/13116320.","journal-title":"Med Clin (Barc)"},{"key":"1247_CR21","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1097\/00002030-199815000-00013","volume":"12","author":"JE Sackoff","year":"1998","unstructured":"Sackoff JE, Torian LV, Frieden TR, Brudney KF, Menzies IB: Purified protein derivative testing and tuberculosis preventive therapy for HIV-infected patients in New York City. AIDS. 1998, 12: 2017-2023. 10.1097\/00002030-199815000-00013.","journal-title":"AIDS"},{"key":"1247_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1164\/rccm.200510-1667OC","volume":"174","author":"FK Shieh","year":"2006","unstructured":"Shieh FK, Snyder G, Horsburgh CR, Bernardo J, Murphy C, Saukkonen JJ: Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med. 2006, 174: 717-721. 10.1164\/rccm.200510-1667OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1247_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00042560-200205010-00014","volume":"30","author":"P Garc\u00eda de Olalla","year":"2002","unstructured":"Garc\u00eda de Olalla P, Knobel H, Carmona A, Guelar A, L\u00f3pez-Colom\u00e9s JL, Cayl\u00e0 JA: Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002, 30: 105-110. 10.1097\/00126334-200205010-00014.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1247_CR24","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/00002030-199910220-00009","volume":"13","author":"MN Gourevitch","year":"1999","unstructured":"Gourevitch MN, Hartel D, Selwyn PA, Schoenbaum EE, Klein RS: Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. AIDS. 1999, 13: 2069-2074. 10.1097\/00002030-199910220-00009.","journal-title":"AIDS"},{"key":"1247_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0213-005X(03)72943-7","volume":"21","author":"J Portilla","year":"2003","unstructured":"Portilla J, Jord\u00e1 P, Esteban J, S\u00e1nchez-Pay\u00e1 J, Merino E, Boix V, Grupo de Estudio Protocolo-INH: Tratamiento directamente observado de la infecci\u00f3n tuberculosa latente: estudio comparativo de dos pautas con isoniacida [Directly observed treatment of latent tuberculosis infection: comparative study of two isoniazid regimens]. Enferm Infecc Microbiol Clin. 2003, 21: 293-295. 10.1157\/13048576.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"1247_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","volume":"351","author":"NA Halsey","year":"1998","unstructured":"Halsey NA, Coberly JS, Desormeaux J, Losikoff P, Atkinson J, Moulton LH, Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R, Chaisson RE: Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet. 1998, 351: 786-792. 10.1016\/S0140-6736(97)06532-X.","journal-title":"Lancet"},{"key":"1247_CR27","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","volume":"12","author":"A Mwinga","year":"1998","unstructured":"Mwinga A, Hosp M, Godfrey-Faussett P, Quigley M, Mwaba P, Mugala BN, Nyirenda O, Luo N, Pobee J, Elliott AM, McAdam KP, Porter JD: Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS. 1998, 12: 2447-2457. 10.1097\/00002030-199818000-00014.","journal-title":"AIDS"},{"key":"1247_CR28","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","volume":"283","author":"F Gordin","year":"2000","unstructured":"Gordin F, Chaisson RE, Matts JP, Miller C, de Lourdes Garcia M, Hafner R, Valdespino JL, Coberly J, Schechter M, Klukowicz AJ, Barry MA, O'Brien RJ: Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group. JAMA. 2000, 283: 1445-1450. 10.1001\/jama.283.11.1445.","journal-title":"JAMA"},{"key":"1247_CR29","first-page":"735","volume":"52","author":"Centers for Disease Control and Prevention (CDC); American Thoracic Society","year":"2003","unstructured":"Centers for Disease Control and Prevention (CDC); American Thoracic Society: Update: adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. MMWR Morb Mortal Wkly Rep. 2003, 52: 735-739.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1247_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1164\/rccm.200510-1563OC","volume":"173","author":"TR Sterling","year":"2006","unstructured":"Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR, Tuberculosis Epidemiologic Studies Cosortium: The scope and impact of treatment of latent tuberculosis infection in the United States and Canada. Am J Respir Crit Care Med. 2006, 173: 927-931. 10.1164\/rccm.200510-1563OC.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-267\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T08:01:01Z","timestamp":1548144061000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1247"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-267","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]},"article-number":"267"}}